We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$28.3B
AUM Growth
+$781M
Cap. Flow
+$1.26B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.95%
Holding
1,427
New
294
Increased
402
Reduced
454
Closed
277

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$245M
2
BKNG icon
Booking.com
BKNG
+$220M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$200M
4
LIN icon
Linde
LIN
+$181M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$178M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$227M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$218M
3
MA icon
Mastercard
MA
+$177M
4
AAPL icon
Apple
AAPL
+$173M
5
CME icon
CME Group
CME
+$116M

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Consumer Discretionary 15.77%
3 Industrials 14.9%
4 Healthcare 14.38%
5 Financials 13.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
1176
Acuity Brands
AYI
$10.8B
-40,110
Closed -$11M
AZEK
1177
DELISTED
The AZEK Co
AZEK
-160,891
Closed -$7.53M
AZUL
1178
DELISTED
Azul
AZUL
-99,325
Closed -$342K
BATRK icon
1179
Atlanta Braves Holdings Series B
BATRK
$3.4B
-11,098
Closed -$442K
BCE icon
1180
BCE
BCE
$21.6B
-879,283
Closed -$30.6M
BCS icon
1181
Barclays
BCS
$94.4B
-2,505,608
Closed -$30.4M
BGS icon
1182
B&G Foods
BGS
$291M
-20,026
Closed -$178K
BIO icon
1183
Bio-Rad Laboratories Class A
BIO
$9.68B
-13,185
Closed -$4.41M
BLCO icon
1184
Bausch + Lomb
BLCO
$5.99B
-125,955
Closed -$2.43M
BLK icon
1185
Blackrock
BLK
$180B
-18,693
Closed -$17.7M
BMY icon
1186
Bristol-Myers Squibb
BMY
$130B
-289,735
Closed -$15M
BRZE icon
1187
Braze
BRZE
$3.12B
-48,960
Closed -$1.58M
BUD icon
1188
AB InBev
BUD
$156B
-218,319
Closed -$14.5M
C icon
1189
Citigroup
C
$231B
-180,028
Closed -$11.3M
CABA icon
1190
Cabaletta Bio
CABA
$465M
-61,842
Closed -$292K
CBRE icon
1191
CBRE Group
CBRE
$42.7B
-264,275
Closed -$32.9M
CCEP icon
1192
Coca-Cola Europacific Partners
CCEP
$47.3B
-148,056
Closed -$11.7M
CDNS icon
1193
Cadence Design Systems
CDNS
$89B
-167,570
Closed -$45.4M
CDNA icon
1194
CareDx
CDNA
$2.45B
-98,136
Closed -$3.06M
CEG icon
1195
Constellation Energy
CEG
$98.7B
-156,166
Closed -$40.6M
CELH icon
1196
Celsius Holdings
CELH
$6.99B
-18,178
Closed -$570K
CENTA icon
1197
Central Garden & Pet Co Class A
CENTA
$2.43B
-45,646
Closed -$1.43M
CFLT
1198
DELISTED
Confluent
CFLT
-81,090
Closed -$1.65M
CHD icon
1199
Church & Dwight Co
CHD
$24B
-186,589
Closed -$19.5M
CHGG icon
1200
Chegg
CHGG
$88.9M
-596,473
Closed -$1.06M

Similar funds

Voloridge Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Voloridge Investment Management held 1,427 positions worth $28.3B, up 2.8% from $27.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Voloridge Investment Management deployed $1.26B of net new capital in Q4 2024, opening 294 new positions and adding to 402 existing holdings. Its largest new stake was Tesla: 762,257 shares worth $308M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $218M trimmed.

  • Voloridge Investment Management's largest Q4 2024 buy was Tesla: 762,257 shares worth $308M.
  • Voloridge Investment Management added most to Booking.com in Q4 2024, an estimated $220M increase.
  • Voloridge Investment Management's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $218M.
  • Voloridge Investment Management fully exited Mercado Libre in Q4 2024, selling an estimated $227M.
  • Voloridge Investment Management's ten largest holdings make up 9% of its $28.3B portfolio in Q4 2024.
  • Voloridge Investment Management opened 294 new positions and closed 277 in Q4 2024.
  • Voloridge Investment Management's portfolio value rose 2.8% quarter-over-quarter to $28.3B.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.